Cargando…
Advances in Natural or Synthetic Nanoparticles for Metastatic Melanoma Therapy and Diagnosis
SIMPLE SUMMARY: Malignant melanoma is the most aggressive skin cancer; its incidence is constantly growing in the white population. In the advanced stage of the disease, after metastatic dissemination, patients have a poor prognosis. Nanomedicine represents a new frontier in cancer treatment; in thi...
Autores principales: | Arasi, Maria Beatrice, Pedini, Francesca, Valentini, Sonia, Felli, Nadia, Felicetti, Federica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601614/ https://www.ncbi.nlm.nih.gov/pubmed/33050185 http://dx.doi.org/10.3390/cancers12102893 |
Ejemplares similares
-
Joint action of miR‐126 and MAPK/PI3K inhibitors against metastatic melanoma
por: Pedini, Francesca, et al.
Publicado: (2019) -
miR-126&126* Restored Expressions Play a Tumor Suppressor Role by Directly Regulating ADAM9 and MMP7 in Melanoma
por: Felli, Nadia, et al.
Publicado: (2013) -
Exosome-mediated transfer of miR-222 is sufficient to increase tumor malignancy in melanoma
por: Felicetti, Federica, et al.
Publicado: (2016) -
AP2α controls the dynamic balance between miR-126&126* and miR-221&222 during melanoma progression
por: Felli, N, et al.
Publicado: (2016) -
The abrogation of the HOXB7/PBX2 complex induces apoptosis in melanoma through the miR-221&222-c-FOS pathway
por: Errico, M Cristina, et al.
Publicado: (2013)